Vestnik Dermatologii i Venerologii (Aug 2017)

Disseminated induced pseudolymphoma DTP vaccine

  • M. G. Harchilava,
  • E. A. Atayan,
  • N. A. Benedik,
  • V. R. Hayrutdinov,
  • I. E. Belousova,
  • A. V. Samtsov

DOI
https://doi.org/10.25208/0042-4609-2016-0-4-61-63
Journal volume & issue
Vol. 0, no. 4
pp. 49 – 53

Abstract

Read online

This article considers the variant of disseminated vaccine-induced pseudolymphoma (VIP), which appeared after the introduction of the DTP vaccine. The article describes features of the observed case: common skin rashes affecting the skin of the face, left and right shoulder, chest and upper back. The effectiveness of topical corticosteroids, calcineurin inhibitors and intralesional injections of betamethasone dipropionate and betamethasone sodium phosphate solution has been shown.

Keywords